 <h1>Onureg Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>azacitidine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about azacitidine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Onureg.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to azacitidine: injection powder for suspension</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, azacitidine (the active ingredient contained in Onureg) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking azacitidine:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bladder pain</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>cloudy urine</li>
<li>body aches or pain</li>
<li>burning or stinging of the skin</li>
<li>chest pain</li>
<li>chills</li>
<li>congestion</li>
<li>cough</li>
<li>difficult breathing</li>
<li>difficulty swallowing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>headache</li>
<li>hives, itching, or skin rash</li>
<li>hoarseness</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>muscle aches</li>
<li>nasal congestion</li>
<li>nausea</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>painful cold sores or blisters on the lips, nose, eyes, or genitals</li>
<li>painful or difficult urination</li>
<li>pain, redness, swelling, tenderness, warmth on the skin</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips or tongue</li>
<li>rapid heartbeat</li>
<li>runny nose</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on lips or in mouth</li>
<li>stuffy nose</li>
<li>swollen glands</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>voice changes</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in consciousness</li>
<li>convulsions</li>
<li>decreased urine</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>increased thirst</li>
<li>irregular heartbeat </li>
<li>loss of appetite</li>
<li>mood changes</li>
<li>muscle pain or cramps</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>loss of consciousness</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking azacitidine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Diarrhea</li>
<li>nausea</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of azacitidine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>appetite decreased</li>
<li>belching</li>
<li>bleeding after defecation</li>
<li>bloody nose</li>
<li>blurred vision</li>
<li>bruise</li>
<li>bumps on the skin</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>burning while urinating</li>
<li>diarrhea</li>
<li>difficulty having a bowel movement (stool)</li>
<li>difficulty with moving</li>
<li>discouragement</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry skin</li>
<li>fainting</li>
<li>fear</li>
<li>feeling of discomfort or illness</li>
<li>feeling of sluggishness</li>
<li>feeling sad or empty</li>
<li>feeling unusually cold</li>
<li>flushing</li>
<li>full or bloated feeling or pressure in the stomach</li>
<li>heartburn</li>
<li>heart murmur</li>
<li>indigestion</li>
<li>inflamed tissue from infection at the injection site</li>
<li>injection site bruising</li>
<li>irritability</li>
<li>itching at injection site</li>
<li>joint pain</li>
<li>lack of appetite</li>
<li>large, flat, blue or purplish patches in the skin</li>
<li>loss of interest or pleasure</li>
<li>mouth hemorrhage</li>
<li>muscle stiffness</li>
<li>nervousness</li>
<li>night sweats</li>
<li>pain in the joints</li>
<li>postnasal drip</li>
<li>post procedural hemorrhage </li>
<li>redness of the skin</li>
<li>shivering</li>
<li>small clicking, bubbling, or rattling sounds in the lung when listening with a stethoscope</li>
<li>small lumps under the skin</li>
<li>small red or purple spots in the mouth</li>
<li>soreness or discomfort to touch or pressure on the stomach</li>
<li>stomach discomfort upset or pain</li>
<li>sweating</li>
<li>swelling of abdominal or stomach area</li>
<li>swelling of the hands, ankles, feet, or lower legs</li>
<li>swelling or inflammation of the mouth</li>
<li>swelling with pits or depressions visible on the skin</li>
<li>swollen joints</li>
<li>tongue ulceration</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>uncomfortable swelling around the anus</li>
<li>unusual drowsiness</li>
<li>unusually warm skin</li>
<li>upper abdominal or stomach pain</li>
<li>weight loss</li>
</ul><p>
<!-- end injection powder for suspension --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to azacitidine: injectable powder for injection, oral tablet, subcutaneous powder for injection</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (71%), vomiting (54%), constipation (50%), diarrhea (36%), abdominal pain (13%), abdominal tenderness (12%)</p>
<p><b>Common</b> (1% to 10%): Gingival bleeding, loose stools, mouth hemorrhage, stomatitis, dyspepsia, diverticulitis, oral fungal infection, GI hemorrhage, hemorrhoidal hemorrhage</p>
<p><b>Frequency not reported</b>: Melena, perirectal abscess<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Thrombocytopenia (70%), anemia (70%), neutropenia (66%), leukopenia (48%), febrile neutropenia (16%)</p>
<p><b>Common</b> (1% to 10%): Aggravated anemia, hematoma, neutropenic sepsis, pancytopenia, bone marrow failure<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (52%), fatigue (24%), chest pain (16%), asthenia (16%), peripheral edema (13%), transfusion reaction (12%)</p>
<p><b>Common</b> (1% to 10%): Malaise, chills, post-procedural hemorrhage, sepsis, herpes simplex</p>
<p><b>Frequency not reported</b>: General physical health deterioration, bacterial infection, blastomycosis, Klebsiella sepsis, septic shock, Staphylococcal bacteremia, Staphylococcal infection, toxoplasmosis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site erythema (43%), injection site reaction (29%), injection site pain (23%), injection site bruising (14%)</p>
<p><b>Common</b> (1% to 10%): Injection site pruritus, injection site granuloma, injection site pigmentation changes, injection site swelling, injection site induration, injection site hematoma, injection site rash, injection site inflammation, injection site discoloration, injection site nodule, injection site hemorrhage, injection site malaise</p>
<p><b>Frequency not reported</b>: Injection site necrosis, catheter site hemorrhage<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Ecchymosis (31%), petechiae (24%), erythema (17%), rash (14%), pruritus (12%)</p>
<p><b>Common</b> (1% to 10%): Dry skin, urticaria, skin nodule, cellulitis, skin infection, purpura, alopecia, erythema, macular rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Sweet's syndrome, pyoderma gangrenosum</p>
<p><b>Frequency not reported</b>: Pruritic rash, skin induration<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (29%), cough (19%), nasopharyngitis (19%), epistaxis (17%), upper respiratory tract infection (13%), pneumonia (13%)</p>
<p><b>Common</b> (1% to 10%): Rhinitis, bronchitis, pharyngolaryngeal pain, exertional dyspnea, sinusitis, pharyngitis, pleural effusion</p>
<p><b>Rare</b> (less than 0.1%): Interstitial lung disease</p>
<p><b>Frequency not reported</b>: Hemoptysis, lung infiltration, pneumonitis, respiratory distress, Streptococcal pharyngitis, Klebsiella pneumonia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (22%), myalgia (16%)</p>
<p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle spasms</p>
<p><b>Frequency not reported</b>: Aggravated bone pain, muscle weakness, neck pain, loin pain, abscess limb</p>
<p><b>Postmarketing reports</b>: Necrotizing fasciitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (22%), dizziness (19%)</p>
<p><b>Common</b> (1% to 10%): Intracranial hemorrhage, syncope, somnolence, lethargy</p>
<p><b>Frequency not reported</b>: Cerebral hemorrhage, convulsions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (21%)</p>
<p><b>Common</b> (1% to 10%): Decreased weight, decreased appetite, hypokalemia, dehydration</p>
<p><b>Rare</b> (less than 0.1%): Tumor lysis syndrome<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Very common</b> (10% or more): Acute myeloid leukemia (14.3%)</p>
<p><b>Frequency not reported</b>: Leukemia cutis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, hypertension, orthostatic hypotension</p>
<p><b>Frequency not reported</b>: Atrial fibrillation, cardiac failure, congestive cardiac failure, cardio-respiratory arrest, congestive cardiomyopathy<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye hemorrhage, conjunctival hemorrhage<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, insomnia, confusional state<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal failure, elevated serum creatinine, hematuria, urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Renal tubular acidosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatic failure, hepatic coma</p>
<p><b>Frequency not reported</b>: Cholecystitis, cholecystectomy<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Anaphylactic shock, systemic inflammatory response syndrome<sup>[Ref]</sup></p><h3>General</h3><p>Most common adverse reactions (greater than 30%) by subcutaneous route are: nausea, anemia, thrombocytopenia, vomiting, pyrexia, leukopenia, diarrhea, injection site erythema, constipation, neutropenia and ecchymosis.  Most common adverse reactions by IV route also included petechiae, rigors, weakness and hypokalemia.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Vidaza (azacitidine)." Celgene Corporation, Summit, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Onureg (azacitidine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Onureg &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Vidaza</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Acute Myeloid Leukemia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to azacitidine: injectable powder for injection, oral tablet, subcutaneous powder for injection</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (71%), vomiting (54%), constipation (50%), diarrhea (36%), abdominal pain (13%), abdominal tenderness (12%)</p><p><b>Common</b> (1% to 10%): Gingival bleeding, loose stools, mouth hemorrhage, stomatitis, dyspepsia, diverticulitis, oral fungal infection, GI hemorrhage, hemorrhoidal hemorrhage</p><p><b>Frequency not reported</b>: Melena, perirectal abscess<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Thrombocytopenia (70%), anemia (70%), neutropenia (66%), leukopenia (48%), febrile neutropenia (16%)</p><p><b>Common</b> (1% to 10%): Aggravated anemia, hematoma, neutropenic sepsis, pancytopenia, bone marrow failure<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (52%), fatigue (24%), chest pain (16%), asthenia (16%), peripheral edema (13%), transfusion reaction (12%)</p><p><b>Common</b> (1% to 10%): Malaise, chills, post-procedural hemorrhage, sepsis, herpes simplex</p><p><b>Frequency not reported</b>: General physical health deterioration, bacterial infection, blastomycosis, Klebsiella sepsis, septic shock, Staphylococcal bacteremia, Staphylococcal infection, toxoplasmosis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site erythema (43%), injection site reaction (29%), injection site pain (23%), injection site bruising (14%)</p><p><b>Common</b> (1% to 10%): Injection site pruritus, injection site granuloma, injection site pigmentation changes, injection site swelling, injection site induration, injection site hematoma, injection site rash, injection site inflammation, injection site discoloration, injection site nodule, injection site hemorrhage, injection site malaise</p><p><b>Frequency not reported</b>: Injection site necrosis, catheter site hemorrhage<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Ecchymosis (31%), petechiae (24%), erythema (17%), rash (14%), pruritus (12%)</p><p><b>Common</b> (1% to 10%): Dry skin, urticaria, skin nodule, cellulitis, skin infection, purpura, alopecia, erythema, macular rash</p><p><b>Uncommon</b> (0.1% to 1%): Sweet's syndrome, pyoderma gangrenosum</p><p><b>Frequency not reported</b>: Pruritic rash, skin induration<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (29%), cough (19%), nasopharyngitis (19%), epistaxis (17%), upper respiratory tract infection (13%), pneumonia (13%)</p><p><b>Common</b> (1% to 10%): Rhinitis, bronchitis, pharyngolaryngeal pain, exertional dyspnea, sinusitis, pharyngitis, pleural effusion</p><p><b>Rare</b> (less than 0.1%): Interstitial lung disease</p><p><b>Frequency not reported</b>: Hemoptysis, lung infiltration, pneumonitis, respiratory distress, Streptococcal pharyngitis, Klebsiella pneumonia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (22%), myalgia (16%)</p><p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle spasms</p><p><b>Frequency not reported</b>: Aggravated bone pain, muscle weakness, neck pain, loin pain, abscess limb</p><p><b>Postmarketing reports</b>: Necrotizing fasciitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (22%), dizziness (19%)</p><p><b>Common</b> (1% to 10%): Intracranial hemorrhage, syncope, somnolence, lethargy</p><p><b>Frequency not reported</b>: Cerebral hemorrhage, convulsions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (21%)</p><p><b>Common</b> (1% to 10%): Decreased weight, decreased appetite, hypokalemia, dehydration</p><p><b>Rare</b> (less than 0.1%): Tumor lysis syndrome<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Very common</b> (10% or more): Acute myeloid leukemia (14.3%)</p><p><b>Frequency not reported</b>: Leukemia cutis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, hypertension, orthostatic hypotension</p><p><b>Frequency not reported</b>: Atrial fibrillation, cardiac failure, congestive cardiac failure, cardio-respiratory arrest, congestive cardiomyopathy<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye hemorrhage, conjunctival hemorrhage<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, insomnia, confusional state<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal failure, elevated serum creatinine, hematuria, urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Renal tubular acidosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Hepatic failure, hepatic coma</p><p><b>Frequency not reported</b>: Cholecystitis, cholecystectomy<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity reactions<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Anaphylactic shock, systemic inflammatory response syndrome<sup>[Ref]</sup></p><h3>General</h3><p>Most common adverse reactions (greater than 30%) by subcutaneous route are: nausea, anemia, thrombocytopenia, vomiting, pyrexia, leukopenia, diarrhea, injection site erythema, constipation, neutropenia and ecchymosis.  Most common adverse reactions by IV route also included petechiae, rigors, weakness and hypokalemia.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Vidaza (azacitidine)." Celgene Corporation, Summit, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Onureg (azacitidine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Onureg &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Acute Myeloid Leukemia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>